JP2021500861A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021500861A5 JP2021500861A5 JP2020517377A JP2020517377A JP2021500861A5 JP 2021500861 A5 JP2021500861 A5 JP 2021500861A5 JP 2020517377 A JP2020517377 A JP 2020517377A JP 2020517377 A JP2020517377 A JP 2020517377A JP 2021500861 A5 JP2021500861 A5 JP 2021500861A5
- Authority
- JP
- Japan
- Prior art keywords
- receptor
- antigen
- cell
- cancer
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000427 antigen Substances 0.000 claims 64
- 108091007433 antigens Proteins 0.000 claims 63
- 102000036639 antigens Human genes 0.000 claims 63
- 206010028980 Neoplasm Diseases 0.000 claims 46
- 210000004027 cell Anatomy 0.000 claims 46
- 108010057466 NF-kappa B Proteins 0.000 claims 45
- 102100023050 Nuclear factor NF-kappa-B p105 subunit Human genes 0.000 claims 45
- 210000002865 immune cell Anatomy 0.000 claims 39
- -1 GFRalpha4 Proteins 0.000 claims 36
- 102000005962 receptors Human genes 0.000 claims 31
- 108020003175 receptors Proteins 0.000 claims 31
- 102000040430 polynucleotide Human genes 0.000 claims 27
- 108091033319 polynucleotide Proteins 0.000 claims 27
- 239000002157 polynucleotide Substances 0.000 claims 27
- 201000011510 cancer Diseases 0.000 claims 26
- 108090000623 proteins and genes Proteins 0.000 claims 26
- 201000001441 melanoma Diseases 0.000 claims 21
- 239000012642 immune effector Substances 0.000 claims 20
- 229940121354 immunomodulator Drugs 0.000 claims 20
- 238000000034 method Methods 0.000 claims 20
- 230000003213 activating effect Effects 0.000 claims 19
- 102100033350 ATP-dependent translocase ABCB1 Human genes 0.000 claims 18
- 101710145634 Antigen 1 Proteins 0.000 claims 18
- 101000633784 Homo sapiens SLAM family member 7 Proteins 0.000 claims 18
- 102100029198 SLAM family member 7 Human genes 0.000 claims 18
- 239000013598 vector Substances 0.000 claims 18
- 108091008874 T cell receptors Proteins 0.000 claims 17
- 239000003795 chemical substances by application Substances 0.000 claims 17
- 210000001744 T-lymphocyte Anatomy 0.000 claims 16
- 201000010099 disease Diseases 0.000 claims 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 16
- 230000037361 pathway Effects 0.000 claims 16
- 102000004169 proteins and genes Human genes 0.000 claims 16
- 241000700605 Viruses Species 0.000 claims 15
- 150000007523 nucleic acids Chemical group 0.000 claims 15
- 102100026094 C-type lectin domain family 12 member A Human genes 0.000 claims 14
- 101710188619 C-type lectin domain family 12 member A Proteins 0.000 claims 14
- 108010047230 Member 1 Subfamily B ATP Binding Cassette Transporter Proteins 0.000 claims 14
- 239000012190 activator Substances 0.000 claims 14
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 claims 13
- 102100025064 Cellular tumor antigen p53 Human genes 0.000 claims 12
- 102100038083 Endosialin Human genes 0.000 claims 12
- 101000721661 Homo sapiens Cellular tumor antigen p53 Proteins 0.000 claims 12
- 108010053099 Vascular Endothelial Growth Factor Receptor-2 Proteins 0.000 claims 12
- 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 claims 12
- 238000003776 cleavage reaction Methods 0.000 claims 12
- 102000039446 nucleic acids Human genes 0.000 claims 12
- 108020004707 nucleic acids Proteins 0.000 claims 12
- 230000007017 scission Effects 0.000 claims 12
- 230000004936 stimulating effect Effects 0.000 claims 12
- 102000048850 Neoplasm Genes Human genes 0.000 claims 11
- 108700019961 Neoplasm Genes Proteins 0.000 claims 11
- 206010039491 Sarcoma Diseases 0.000 claims 11
- 239000012634 fragment Substances 0.000 claims 11
- 108090000765 processed proteins & peptides Proteins 0.000 claims 11
- 210000000130 stem cell Anatomy 0.000 claims 11
- 102000009465 Growth Factor Receptors Human genes 0.000 claims 10
- 108010009202 Growth Factor Receptors Proteins 0.000 claims 10
- 101000878602 Homo sapiens Immunoglobulin alpha Fc receptor Proteins 0.000 claims 10
- 102100038005 Immunoglobulin alpha Fc receptor Human genes 0.000 claims 10
- 229920001184 polypeptide Polymers 0.000 claims 10
- 102000004196 processed proteins & peptides Human genes 0.000 claims 10
- 102100022748 Wilms tumor protein Human genes 0.000 claims 9
- 101710127857 Wilms tumor protein Proteins 0.000 claims 9
- 102000016914 ras Proteins Human genes 0.000 claims 9
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims 8
- RJBDSRWGVYNDHL-XNJNKMBASA-N (2S,4R,5S,6S)-2-[(2S,3R,4R,5S,6R)-5-[(2S,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-[(2R,3S,4R,5R,6R)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(E,2R,3S)-3-hydroxy-2-(octadecanoylamino)octadec-4-enoxy]oxan-3-yl]oxy-3-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-5-amino-6-[(1S,2R)-2-[(2S,4R,5S,6S)-5-amino-2-carboxy-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl]oxy-1,3-dihydroxypropyl]-4-hydroxyoxane-2-carboxylic acid Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3NC(C)=O)[C@H](O[C@@]3(C[C@@H](O)[C@H](N)[C@H](O3)[C@H](O)[C@@H](CO)O[C@@]3(C[C@@H](O)[C@H](N)[C@H](O3)[C@H](O)[C@H](O)CO)C(O)=O)C(O)=O)[C@H]2O)[C@H](O)[C@H]1O)[C@@H](O)\C=C\CCCCCCCCCCCCC RJBDSRWGVYNDHL-XNJNKMBASA-N 0.000 claims 8
- LTHJXDSHSVNJKG-UHFFFAOYSA-N 2-[2-[2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethoxy]ethoxy]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOCCOCCOC(=O)C(C)=C LTHJXDSHSVNJKG-UHFFFAOYSA-N 0.000 claims 8
- 101710109924 A-kinase anchor protein 4 Proteins 0.000 claims 8
- 102100029824 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2 Human genes 0.000 claims 8
- 102100037982 Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A Human genes 0.000 claims 8
- 102100038078 CD276 antigen Human genes 0.000 claims 8
- 102100029390 CMRF35-like molecule 1 Human genes 0.000 claims 8
- 108091006027 G proteins Proteins 0.000 claims 8
- 102100021197 G-protein coupled receptor family C group 5 member D Human genes 0.000 claims 8
- 102000030782 GTP binding Human genes 0.000 claims 8
- 108091000058 GTP-Binding Proteins 0.000 claims 8
- 102100031547 HLA class II histocompatibility antigen, DO alpha chain Human genes 0.000 claims 8
- 101710154606 Hemagglutinin Proteins 0.000 claims 8
- 101000794082 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2 Proteins 0.000 claims 8
- 101000884279 Homo sapiens CD276 antigen Proteins 0.000 claims 8
- 101000990055 Homo sapiens CMRF35-like molecule 1 Proteins 0.000 claims 8
- 101000884275 Homo sapiens Endosialin Proteins 0.000 claims 8
- 101001040713 Homo sapiens G-protein coupled receptor family C group 5 member D Proteins 0.000 claims 8
- 101000866278 Homo sapiens HLA class II histocompatibility antigen, DO alpha chain Proteins 0.000 claims 8
- 101000608935 Homo sapiens Leukosialin Proteins 0.000 claims 8
- 101000917826 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor II-a Proteins 0.000 claims 8
- 101000824971 Homo sapiens Sperm surface protein Sp17 Proteins 0.000 claims 8
- 101000894428 Homo sapiens Transcriptional repressor CTCFL Proteins 0.000 claims 8
- 102100029616 Immunoglobulin lambda-like polypeptide 1 Human genes 0.000 claims 8
- 101710107067 Immunoglobulin lambda-like polypeptide 1 Proteins 0.000 claims 8
- 102100031413 L-dopachrome tautomerase Human genes 0.000 claims 8
- 108010011942 LH Receptors Proteins 0.000 claims 8
- 102100025586 Leukocyte immunoglobulin-like receptor subfamily A member 2 Human genes 0.000 claims 8
- 101710196509 Leukocyte immunoglobulin-like receptor subfamily A member 2 Proteins 0.000 claims 8
- 102100039564 Leukosialin Human genes 0.000 claims 8
- 102100029204 Low affinity immunoglobulin gamma Fc region receptor II-a Human genes 0.000 claims 8
- 102100040788 Lutropin-choriogonadotropic hormone receptor Human genes 0.000 claims 8
- 102100033486 Lymphocyte antigen 75 Human genes 0.000 claims 8
- 101710157884 Lymphocyte antigen 75 Proteins 0.000 claims 8
- 206010025323 Lymphomas Diseases 0.000 claims 8
- 101710093908 Outer capsid protein VP4 Proteins 0.000 claims 8
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 claims 8
- 101710176177 Protein A56 Proteins 0.000 claims 8
- 102100038098 Protein-glutamine gamma-glutamyltransferase 5 Human genes 0.000 claims 8
- 102100020718 Receptor-type tyrosine-protein kinase FLT3 Human genes 0.000 claims 8
- 102100021393 Transcriptional repressor CTCFL Human genes 0.000 claims 8
- 102100031989 Transmembrane protease serine 2 Human genes 0.000 claims 8
- 108010034034 alpha-1,6-mannosylglycoprotein beta 1,6-N-acetylglucosaminyltransferase Proteins 0.000 claims 8
- 150000001875 compounds Chemical class 0.000 claims 8
- 108010051081 dopachrome isomerase Proteins 0.000 claims 8
- 230000008472 epithelial growth Effects 0.000 claims 8
- 108010003374 fms-Like Tyrosine Kinase 3 Proteins 0.000 claims 8
- 239000000185 hemagglutinin Substances 0.000 claims 8
- 125000005630 sialyl group Chemical group 0.000 claims 8
- 230000002381 testicular Effects 0.000 claims 8
- 108010058721 transglutaminase 5 Proteins 0.000 claims 8
- 230000005945 translocation Effects 0.000 claims 8
- 108010051118 Bone Marrow Stromal Antigen 2 Proteins 0.000 claims 7
- 102100037086 Bone marrow stromal antigen 2 Human genes 0.000 claims 7
- 102100025570 Cancer/testis antigen 1 Human genes 0.000 claims 7
- 102100031507 Fc receptor-like protein 5 Human genes 0.000 claims 7
- 102100041003 Glutamate carboxypeptidase 2 Human genes 0.000 claims 7
- 101000846908 Homo sapiens Fc receptor-like protein 5 Proteins 0.000 claims 7
- 101000892862 Homo sapiens Glutamate carboxypeptidase 2 Proteins 0.000 claims 7
- 101000971605 Homo sapiens Kita-kyushu lung cancer antigen 1 Proteins 0.000 claims 7
- 101000655352 Homo sapiens Telomerase reverse transcriptase Proteins 0.000 claims 7
- 101001047681 Homo sapiens Tyrosine-protein kinase Lck Proteins 0.000 claims 7
- 241000701806 Human papillomavirus Species 0.000 claims 7
- 102100039688 Insulin-like growth factor 1 receptor Human genes 0.000 claims 7
- 102100021533 Kita-kyushu lung cancer antigen 1 Human genes 0.000 claims 7
- 102100026181 Placenta-specific protein 1 Human genes 0.000 claims 7
- 108050005093 Placenta-specific protein 1 Proteins 0.000 claims 7
- 102100023832 Prolyl endopeptidase FAP Human genes 0.000 claims 7
- 102100035703 Prostatic acid phosphatase Human genes 0.000 claims 7
- 102000004245 Proteasome Endopeptidase Complex Human genes 0.000 claims 7
- 108090000708 Proteasome Endopeptidase Complex Proteins 0.000 claims 7
- 102000003911 Thyrotropin Receptors Human genes 0.000 claims 7
- 108090000253 Thyrotropin Receptors Proteins 0.000 claims 7
- 102100024036 Tyrosine-protein kinase Lck Human genes 0.000 claims 7
- 102000013532 Uroplakin II Human genes 0.000 claims 7
- 108010065940 Uroplakin II Proteins 0.000 claims 7
- 108010072257 fibroblast activation protein alpha Proteins 0.000 claims 7
- 230000004927 fusion Effects 0.000 claims 7
- 108020001507 fusion proteins Proteins 0.000 claims 7
- 102000037865 fusion proteins Human genes 0.000 claims 7
- 108010043671 prostatic acid phosphatase Proteins 0.000 claims 7
- 102100039510 Cancer/testis antigen 2 Human genes 0.000 claims 6
- 102000016289 Cell Adhesion Molecules Human genes 0.000 claims 6
- 108010067225 Cell Adhesion Molecules Proteins 0.000 claims 6
- 102000003886 Glycoproteins Human genes 0.000 claims 6
- 108090000288 Glycoproteins Proteins 0.000 claims 6
- 101000691214 Haloarcula marismortui (strain ATCC 43049 / DSM 3752 / JCM 8966 / VKM B-1809) 50S ribosomal protein L44e Proteins 0.000 claims 6
- 241000713772 Human immunodeficiency virus 1 Species 0.000 claims 6
- 101710123134 Ice-binding protein Proteins 0.000 claims 6
- 101710082837 Ice-structuring protein Proteins 0.000 claims 6
- 102100026547 Platelet-derived growth factor receptor beta Human genes 0.000 claims 6
- 102100034196 Thrombopoietin receptor Human genes 0.000 claims 6
- 102100034593 Tripartite motif-containing protein 26 Human genes 0.000 claims 6
- 101710107540 Type-2 ice-structuring protein Proteins 0.000 claims 6
- 230000000735 allogeneic effect Effects 0.000 claims 6
- 108040005514 choriogonadotropin hormone receptor activity proteins Proteins 0.000 claims 6
- 102000027596 immune receptors Human genes 0.000 claims 6
- 108091008915 immune receptors Proteins 0.000 claims 6
- 239000003112 inhibitor Substances 0.000 claims 6
- 206010000830 Acute leukaemia Diseases 0.000 claims 5
- 108010019670 Chimeric Antigen Receptors Proteins 0.000 claims 5
- 102000004190 Enzymes Human genes 0.000 claims 5
- 108090000790 Enzymes Proteins 0.000 claims 5
- 101000856237 Homo sapiens Cancer/testis antigen 1 Proteins 0.000 claims 5
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 claims 5
- 102100025128 Olfactory receptor 51E2 Human genes 0.000 claims 5
- 101710187841 Olfactory receptor 51E2 Proteins 0.000 claims 5
- 108091000080 Phosphotransferase Proteins 0.000 claims 5
- 101710164680 Platelet-derived growth factor receptor beta Proteins 0.000 claims 5
- 108010017842 Telomerase Proteins 0.000 claims 5
- 210000003958 hematopoietic stem cell Anatomy 0.000 claims 5
- 108091008039 hormone receptors Proteins 0.000 claims 5
- 208000032839 leukemia Diseases 0.000 claims 5
- 102000020233 phosphotransferase Human genes 0.000 claims 5
- 230000001105 regulatory effect Effects 0.000 claims 5
- 230000019491 signal transduction Effects 0.000 claims 5
- WEVYNIUIFUYDGI-UHFFFAOYSA-N 3-[6-[4-(trifluoromethoxy)anilino]-4-pyrimidinyl]benzamide Chemical compound NC(=O)C1=CC=CC(C=2N=CN=C(NC=3C=CC(OC(F)(F)F)=CC=3)C=2)=C1 WEVYNIUIFUYDGI-UHFFFAOYSA-N 0.000 claims 4
- 102100031585 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Human genes 0.000 claims 4
- 102100022907 Acrosin-binding protein Human genes 0.000 claims 4
- 101710107749 Acrosin-binding protein Proteins 0.000 claims 4
- 102100026402 Adhesion G protein-coupled receptor E2 Human genes 0.000 claims 4
- 102100026423 Adhesion G protein-coupled receptor E5 Human genes 0.000 claims 4
- UCTWMZQNUQWSLP-UHFFFAOYSA-N Adrenaline Natural products CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 claims 4
- 102100032187 Androgen receptor Human genes 0.000 claims 4
- 102100023003 Ankyrin repeat domain-containing protein 30A Human genes 0.000 claims 4
- 229940088872 Apoptosis inhibitor Drugs 0.000 claims 4
- 102100025218 B-cell differentiation antigen CD72 Human genes 0.000 claims 4
- 102100038080 B-cell receptor CD22 Human genes 0.000 claims 4
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 claims 4
- 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 claims 4
- 102100027522 Baculoviral IAP repeat-containing protein 7 Human genes 0.000 claims 4
- 101710149863 C-C chemokine receptor type 4 Proteins 0.000 claims 4
- 102100023458 C-type lectin-like domain family 1 Human genes 0.000 claims 4
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims 4
- 102100032976 CCR4-NOT transcription complex subunit 6 Human genes 0.000 claims 4
- 108010058905 CD44v6 antigen Proteins 0.000 claims 4
- 102000024905 CD99 Human genes 0.000 claims 4
- 108060001253 CD99 Proteins 0.000 claims 4
- 108091008048 CMVpp65 Proteins 0.000 claims 4
- 102100024152 Cadherin-17 Human genes 0.000 claims 4
- 102100022529 Cadherin-19 Human genes 0.000 claims 4
- 102100029756 Cadherin-6 Human genes 0.000 claims 4
- 101100518995 Caenorhabditis elegans pax-3 gene Proteins 0.000 claims 4
- ODINCKMPIJJUCX-UHFFFAOYSA-N Calcium oxide Chemical compound [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 claims 4
- 102000013392 Carboxylesterase Human genes 0.000 claims 4
- 108010051152 Carboxylesterase Proteins 0.000 claims 4
- 102000000844 Cell Surface Receptors Human genes 0.000 claims 4
- 108010001857 Cell Surface Receptors Proteins 0.000 claims 4
- 102100021396 Cell surface glycoprotein CD200 receptor 1 Human genes 0.000 claims 4
- 101710181340 Chaperone protein DnaK2 Proteins 0.000 claims 4
- 108010062745 Chloride Channels Proteins 0.000 claims 4
- 102000011045 Chloride Channels Human genes 0.000 claims 4
- 102100035167 Coiled-coil domain-containing protein 54 Human genes 0.000 claims 4
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 claims 4
- 102000003849 Cytochrome P450 Human genes 0.000 claims 4
- 101100481408 Danio rerio tie2 gene Proteins 0.000 claims 4
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 claims 4
- 101150029707 ERBB2 gene Proteins 0.000 claims 4
- 102100031334 Elongation factor 2 Human genes 0.000 claims 4
- 101710144543 Endosialin Proteins 0.000 claims 4
- 241000709661 Enterovirus Species 0.000 claims 4
- 108010055196 EphA2 Receptor Proteins 0.000 claims 4
- 102100030340 Ephrin type-A receptor 2 Human genes 0.000 claims 4
- 102000010449 Folate receptor beta Human genes 0.000 claims 4
- 108050001930 Folate receptor beta Proteins 0.000 claims 4
- 102000003817 Fos-related antigen 1 Human genes 0.000 claims 4
- 108090000123 Fos-related antigen 1 Proteins 0.000 claims 4
- 102000044445 Galectin-8 Human genes 0.000 claims 4
- 108091022930 Glutamate decarboxylase Proteins 0.000 claims 4
- 102100035902 Glutamate decarboxylase 1 Human genes 0.000 claims 4
- 101150112082 Gpnmb gene Proteins 0.000 claims 4
- 102100028113 Granulocyte-macrophage colony-stimulating factor receptor subunit alpha Human genes 0.000 claims 4
- 102100028976 HLA class I histocompatibility antigen, B alpha chain Human genes 0.000 claims 4
- 102100028971 HLA class I histocompatibility antigen, C alpha chain Human genes 0.000 claims 4
- 102100028967 HLA class I histocompatibility antigen, alpha chain G Human genes 0.000 claims 4
- 102100031546 HLA class II histocompatibility antigen, DO beta chain Human genes 0.000 claims 4
- 102000025850 HLA-A2 Antigen Human genes 0.000 claims 4
- 108010074032 HLA-A2 Antigen Proteins 0.000 claims 4
- 108010058607 HLA-B Antigens Proteins 0.000 claims 4
- 108010052199 HLA-C Antigens Proteins 0.000 claims 4
- 108010010378 HLA-DP Antigens Proteins 0.000 claims 4
- 102000015789 HLA-DP Antigens Human genes 0.000 claims 4
- 108010062347 HLA-DQ Antigens Proteins 0.000 claims 4
- 108010058597 HLA-DR Antigens Proteins 0.000 claims 4
- 102000006354 HLA-DR Antigens Human genes 0.000 claims 4
- 108010024164 HLA-G Antigens Proteins 0.000 claims 4
- 101710178419 Heat shock protein 70 2 Proteins 0.000 claims 4
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims 4
- 241000709721 Hepatovirus A Species 0.000 claims 4
- 101100118545 Holotrichia diomphalia EGF-like gene Proteins 0.000 claims 4
- 101000777636 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Proteins 0.000 claims 4
- 101001017818 Homo sapiens ATP-dependent translocase ABCB1 Proteins 0.000 claims 4
- 101000718211 Homo sapiens Adhesion G protein-coupled receptor E2 Proteins 0.000 claims 4
- 101000718243 Homo sapiens Adhesion G protein-coupled receptor E5 Proteins 0.000 claims 4
- 101000757191 Homo sapiens Ankyrin repeat domain-containing protein 30A Proteins 0.000 claims 4
- 101000934359 Homo sapiens B-cell differentiation antigen CD72 Proteins 0.000 claims 4
- 101000884305 Homo sapiens B-cell receptor CD22 Proteins 0.000 claims 4
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 claims 4
- 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 claims 4
- 101000936083 Homo sapiens Baculoviral IAP repeat-containing protein 7 Proteins 0.000 claims 4
- 101000906643 Homo sapiens C-type lectin-like domain family 1 Proteins 0.000 claims 4
- 101000762247 Homo sapiens Cadherin-17 Proteins 0.000 claims 4
- 101000899410 Homo sapiens Cadherin-19 Proteins 0.000 claims 4
- 101000794604 Homo sapiens Cadherin-6 Proteins 0.000 claims 4
- 101000889345 Homo sapiens Cancer/testis antigen 2 Proteins 0.000 claims 4
- 101000969553 Homo sapiens Cell surface glycoprotein CD200 receptor 1 Proteins 0.000 claims 4
- 101000737052 Homo sapiens Coiled-coil domain-containing protein 54 Proteins 0.000 claims 4
- 101001099051 Homo sapiens GPI inositol-deacylase Proteins 0.000 claims 4
- 101000608769 Homo sapiens Galectin-8 Proteins 0.000 claims 4
- 101000916625 Homo sapiens Granulocyte-macrophage colony-stimulating factor receptor subunit alpha Proteins 0.000 claims 4
- 101000866281 Homo sapiens HLA class II histocompatibility antigen, DO beta chain Proteins 0.000 claims 4
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims 4
- 101000606465 Homo sapiens Inactive tyrosine-protein kinase 7 Proteins 0.000 claims 4
- 101000917824 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor II-b Proteins 0.000 claims 4
- 101001014223 Homo sapiens MAPK/MAK/MRK overlapping kinase Proteins 0.000 claims 4
- 101000628547 Homo sapiens Metalloreductase STEAP1 Proteins 0.000 claims 4
- 101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 claims 4
- 101001109501 Homo sapiens NKG2-D type II integral membrane protein Proteins 0.000 claims 4
- 101001117317 Homo sapiens Programmed cell death 1 ligand 1 Proteins 0.000 claims 4
- 101000633786 Homo sapiens SLAM family member 6 Proteins 0.000 claims 4
- 101000884271 Homo sapiens Signal transducer CD24 Proteins 0.000 claims 4
- 101000714168 Homo sapiens Testisin Proteins 0.000 claims 4
- 101000638154 Homo sapiens Transmembrane protease serine 2 Proteins 0.000 claims 4
- 101000851376 Homo sapiens Tumor necrosis factor receptor superfamily member 8 Proteins 0.000 claims 4
- 102100039813 Inactive tyrosine-protein kinase 7 Human genes 0.000 claims 4
- 102100039615 Inactive tyrosine-protein kinase transmembrane receptor ROR1 Human genes 0.000 claims 4
- 101710184277 Insulin-like growth factor 1 receptor Proteins 0.000 claims 4
- 102000004553 Interleukin-11 Receptors Human genes 0.000 claims 4
- 108010017521 Interleukin-11 Receptors Proteins 0.000 claims 4
- 102100020793 Interleukin-13 receptor subunit alpha-2 Human genes 0.000 claims 4
- 101710112634 Interleukin-13 receptor subunit alpha-2 Proteins 0.000 claims 4
- 102100034872 Kallikrein-4 Human genes 0.000 claims 4
- 108010009254 Lysosomal-Associated Membrane Protein 1 Proteins 0.000 claims 4
- 102100035133 Lysosome-associated membrane glycoprotein 1 Human genes 0.000 claims 4
- 102100031520 MAPK/MAK/MRK overlapping kinase Human genes 0.000 claims 4
- 108700012912 MYCN Proteins 0.000 claims 4
- 101150022024 MYCN gene Proteins 0.000 claims 4
- 102100026712 Metalloreductase STEAP1 Human genes 0.000 claims 4
- 101100010421 Mus musculus Dsg1a gene Proteins 0.000 claims 4
- 101100518997 Mus musculus Pax3 gene Proteins 0.000 claims 4
- 101100351020 Mus musculus Pax5 gene Proteins 0.000 claims 4
- 101100481410 Mus musculus Tek gene Proteins 0.000 claims 4
- 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 claims 4
- 108700026495 N-Myc Proto-Oncogene Proteins 0.000 claims 4
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims 4
- 102100030124 N-myc proto-oncogene protein Human genes 0.000 claims 4
- 102100022680 NKG2-D type II integral membrane protein Human genes 0.000 claims 4
- 102100038082 Natural killer cell receptor 2B4 Human genes 0.000 claims 4
- 101710141230 Natural killer cell receptor 2B4 Proteins 0.000 claims 4
- 101710043865 Nectin-4 Proteins 0.000 claims 4
- 102100035486 Nectin-4 Human genes 0.000 claims 4
- 102100024964 Neural cell adhesion molecule L1 Human genes 0.000 claims 4
- 206010029260 Neuroblastoma Diseases 0.000 claims 4
- KUIFHYPNNRVEKZ-VIJRYAKMSA-N O-(N-acetyl-alpha-D-galactosaminyl)-L-threonine Chemical compound OC(=O)[C@@H](N)[C@@H](C)O[C@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1NC(C)=O KUIFHYPNNRVEKZ-VIJRYAKMSA-N 0.000 claims 4
- 102100040891 Paired box protein Pax-3 Human genes 0.000 claims 4
- 101710149060 Paired box protein Pax-3 Proteins 0.000 claims 4
- 102100037504 Paired box protein Pax-5 Human genes 0.000 claims 4
- 101710149067 Paired box protein Pax-5 Proteins 0.000 claims 4
- 108010077519 Peptide Elongation Factor 2 Proteins 0.000 claims 4
- 102100037891 Plexin domain-containing protein 1 Human genes 0.000 claims 4
- 108050009432 Plexin domain-containing protein 1 Proteins 0.000 claims 4
- 102100024216 Programmed cell death 1 ligand 1 Human genes 0.000 claims 4
- 206010060862 Prostate cancer Diseases 0.000 claims 4
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 4
- 108010006700 Receptor Tyrosine Kinase-like Orphan Receptors Proteins 0.000 claims 4
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 claims 4
- 101710100968 Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 claims 4
- 102100029197 SLAM family member 6 Human genes 0.000 claims 4
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 4
- 102100038081 Signal transducer CD24 Human genes 0.000 claims 4
- 102100022441 Sperm surface protein Sp17 Human genes 0.000 claims 4
- 101800001271 Surface protein Proteins 0.000 claims 4
- 101150117918 Tacstd2 gene Proteins 0.000 claims 4
- 102000013980 Testisin Human genes 0.000 claims 4
- 102100036494 Testisin Human genes 0.000 claims 4
- 108050003829 Testisin Proteins 0.000 claims 4
- 108010000499 Thromboplastin Proteins 0.000 claims 4
- 102100030859 Tissue factor Human genes 0.000 claims 4
- 101710081844 Transmembrane protease serine 2 Proteins 0.000 claims 4
- 108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 claims 4
- 102100036857 Tumor necrosis factor receptor superfamily member 8 Human genes 0.000 claims 4
- 102100027212 Tumor-associated calcium signal transducer 2 Human genes 0.000 claims 4
- 102000003425 Tyrosinase Human genes 0.000 claims 4
- 108060008724 Tyrosinase Proteins 0.000 claims 4
- 101100351021 Xenopus laevis pax5 gene Proteins 0.000 claims 4
- 239000002253 acid Substances 0.000 claims 4
- RJURFGZVJUQBHK-UHFFFAOYSA-N actinomycin D Natural products CC1OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C(=O)C(C(C)C)NC(=O)C1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)NC4C(=O)NC(C(N5CCCC5C(=O)N(C)CC(=O)N(C)C(C(C)C)C(=O)OC4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-UHFFFAOYSA-N 0.000 claims 4
- 230000004913 activation Effects 0.000 claims 4
- 108010080146 androgen receptors Proteins 0.000 claims 4
- 239000000158 apoptosis inhibitor Substances 0.000 claims 4
- 210000003719 b-lymphocyte Anatomy 0.000 claims 4
- 229960002685 biotin Drugs 0.000 claims 4
- 235000020958 biotin Nutrition 0.000 claims 4
- 239000011616 biotin Substances 0.000 claims 4
- 230000011748 cell maturation Effects 0.000 claims 4
- 229940106189 ceramide Drugs 0.000 claims 4
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims 4
- 210000000349 chromosome Anatomy 0.000 claims 4
- 230000004069 differentiation Effects 0.000 claims 4
- 229940079593 drug Drugs 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 230000001605 fetal effect Effects 0.000 claims 4
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 claims 4
- 102000006815 folate receptor Human genes 0.000 claims 4
- 108020005243 folate receptor Proteins 0.000 claims 4
- 102000011778 gamma-delta T-Cell Antigen Receptors Human genes 0.000 claims 4
- 108010062214 gamma-delta T-Cell Antigen Receptors Proteins 0.000 claims 4
- PFJKOHUKELZMLE-VEUXDRLPSA-N ganglioside GM3 Chemical compound O[C@@H]1[C@@H](O)[C@H](OC[C@@H]([C@H](O)/C=C/CCCCCCCCCCCCC)NC(=O)CCCCCCCCCCCCC\C=C/CCCCCCCC)O[C@H](CO)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@]2(O[C@H]([C@H](NC(C)=O)[C@@H](O)C2)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O)[C@@H](CO)O1 PFJKOHUKELZMLE-VEUXDRLPSA-N 0.000 claims 4
- 150000002270 gangliosides Chemical class 0.000 claims 4
- 201000005787 hematologic cancer Diseases 0.000 claims 4
- 208000024200 hematopoietic and lymphoid system neoplasm Diseases 0.000 claims 4
- 239000005556 hormone Substances 0.000 claims 4
- 229940088597 hormone Drugs 0.000 claims 4
- 208000037797 influenza A Diseases 0.000 claims 4
- 108010024383 kallikrein 4 Proteins 0.000 claims 4
- 210000003734 kidney Anatomy 0.000 claims 4
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims 4
- 101710135378 pH 6 antigen Proteins 0.000 claims 4
- 102200006531 rs121913529 Human genes 0.000 claims 4
- 210000001550 testis Anatomy 0.000 claims 4
- 102000003298 tumor necrosis factor receptor Human genes 0.000 claims 4
- 102100038449 Claudin-6 Human genes 0.000 claims 3
- 108090000229 Claudin-6 Proteins 0.000 claims 3
- 108091026890 Coding region Proteins 0.000 claims 3
- 102000016736 Cyclin Human genes 0.000 claims 3
- 108050006400 Cyclin Proteins 0.000 claims 3
- 102100036466 Delta-like protein 3 Human genes 0.000 claims 3
- 102100038132 Endogenous retrovirus group K member 6 Pro protein Human genes 0.000 claims 3
- 102000000820 Enterotoxin Receptors Human genes 0.000 claims 3
- 108010001687 Enterotoxin Receptors Proteins 0.000 claims 3
- 102100023721 Ephrin-B2 Human genes 0.000 claims 3
- 108010044090 Ephrin-B2 Proteins 0.000 claims 3
- 102100028972 HLA class I histocompatibility antigen, A alpha chain Human genes 0.000 claims 3
- 108010075704 HLA-A Antigens Proteins 0.000 claims 3
- 101000928513 Homo sapiens Delta-like protein 3 Proteins 0.000 claims 3
- 101000972796 Homo sapiens NF-kappa-B-activating protein Proteins 0.000 claims 3
- 241001502974 Human gammaherpesvirus 8 Species 0.000 claims 3
- 101000850887 Human herpesvirus 8 type P (isolate GK18) Viral FLICE protein Proteins 0.000 claims 3
- 108010031794 IGF Type 1 Receptor Proteins 0.000 claims 3
- 102100020943 Leukocyte-associated immunoglobulin-like receptor 1 Human genes 0.000 claims 3
- 102100022580 NF-kappa-B-activating protein Human genes 0.000 claims 3
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 3
- 108091005804 Peptidases Proteins 0.000 claims 3
- 239000004365 Protease Substances 0.000 claims 3
- 108010027179 Tacrolimus Binding Proteins Proteins 0.000 claims 3
- 102000018679 Tacrolimus Binding Proteins Human genes 0.000 claims 3
- 101710101493 Viral myc transforming protein Proteins 0.000 claims 3
- 210000000481 breast Anatomy 0.000 claims 3
- 229940127276 delta-like ligand 3 Drugs 0.000 claims 3
- 230000000694 effects Effects 0.000 claims 3
- 230000003325 follicular Effects 0.000 claims 3
- 238000010362 genome editing Methods 0.000 claims 3
- 208000015181 infectious disease Diseases 0.000 claims 3
- 230000000968 intestinal effect Effects 0.000 claims 3
- 108010025001 leukocyte-associated immunoglobulin-like receptor 1 Proteins 0.000 claims 3
- 210000004698 lymphocyte Anatomy 0.000 claims 3
- 210000000581 natural killer T-cell Anatomy 0.000 claims 3
- 210000002569 neuron Anatomy 0.000 claims 3
- 239000002243 precursor Substances 0.000 claims 3
- 210000003289 regulatory T cell Anatomy 0.000 claims 3
- 108010088201 squamous cell carcinoma-related antigen Proteins 0.000 claims 3
- 239000000758 substrate Substances 0.000 claims 3
- 206010042863 synovial sarcoma Diseases 0.000 claims 3
- KZMAWJRXKGLWGS-UHFFFAOYSA-N 2-chloro-n-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-n-(3-methoxypropyl)acetamide Chemical compound S1C(N(C(=O)CCl)CCCOC)=NC(C=2C=CC(OC)=CC=2)=C1 KZMAWJRXKGLWGS-UHFFFAOYSA-N 0.000 claims 2
- 208000024893 Acute lymphoblastic leukemia Diseases 0.000 claims 2
- 208000014697 Acute lymphocytic leukaemia Diseases 0.000 claims 2
- 101100208111 Arabidopsis thaliana TRX5 gene Proteins 0.000 claims 2
- 208000025324 B-cell acute lymphoblastic leukemia Diseases 0.000 claims 2
- 101710120600 Cancer/testis antigen 1 Proteins 0.000 claims 2
- 101710120595 Cancer/testis antigen 2 Proteins 0.000 claims 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims 2
- 102100034231 Cell surface A33 antigen Human genes 0.000 claims 2
- 241000701022 Cytomegalovirus Species 0.000 claims 2
- 108010092160 Dactinomycin Proteins 0.000 claims 2
- 101100508533 Drosophila melanogaster IKKbeta gene Proteins 0.000 claims 2
- 108010066687 Epithelial Cell Adhesion Molecule Proteins 0.000 claims 2
- 102100031940 Epithelial cell adhesion molecule Human genes 0.000 claims 2
- 102000006771 Gonadotropins Human genes 0.000 claims 2
- 108010086677 Gonadotropins Proteins 0.000 claims 2
- 208000017604 Hodgkin disease Diseases 0.000 claims 2
- 208000010747 Hodgkins lymphoma Diseases 0.000 claims 2
- 101000996823 Homo sapiens Cell surface A33 antigen Proteins 0.000 claims 2
- 101100420560 Homo sapiens SLC39A6 gene Proteins 0.000 claims 2
- 101000799466 Homo sapiens Thrombopoietin receptor Proteins 0.000 claims 2
- 108010042653 IgA receptor Proteins 0.000 claims 2
- 102000018071 Immunoglobulin Fc Fragments Human genes 0.000 claims 2
- 108010091135 Immunoglobulin Fc Fragments Proteins 0.000 claims 2
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims 2
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims 2
- 102000016200 MART-1 Antigen Human genes 0.000 claims 2
- 108010010995 MART-1 Antigen Proteins 0.000 claims 2
- 102000003735 Mesothelin Human genes 0.000 claims 2
- 108090000015 Mesothelin Proteins 0.000 claims 2
- 229930012538 Paclitaxel Natural products 0.000 claims 2
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 claims 2
- 208000009052 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 claims 2
- 101710120463 Prostate stem cell antigen Proteins 0.000 claims 2
- 102100036735 Prostate stem cell antigen Human genes 0.000 claims 2
- 208000015634 Rectal Neoplasms Diseases 0.000 claims 2
- 208000029052 T-cell acute lymphoblastic leukemia Diseases 0.000 claims 2
- 208000006593 Urologic Neoplasms Diseases 0.000 claims 2
- 208000002495 Uterine Neoplasms Diseases 0.000 claims 2
- 102100023144 Zinc transporter ZIP6 Human genes 0.000 claims 2
- GQLCLPLEEOUJQC-ZTQDTCGGSA-N [(1r)-3-(3,4-dimethoxyphenyl)-1-[3-[2-[2-[[2-[3-[(1r)-3-(3,4-dimethoxyphenyl)-1-[(2s)-1-[(2s)-2-(3,4,5-trimethoxyphenyl)butanoyl]piperidine-2-carbonyl]oxypropyl]phenoxy]acetyl]amino]ethylamino]-2-oxoethoxy]phenyl]propyl] (2s)-1-[(2s)-2-(3,4,5-trimethoxyph Chemical compound C([C@@H](OC(=O)[C@@H]1CCCCN1C(=O)[C@@H](CC)C=1C=C(OC)C(OC)=C(OC)C=1)C=1C=C(OCC(=O)NCCNC(=O)COC=2C=C(C=CC=2)[C@@H](CCC=2C=C(OC)C(OC)=CC=2)OC(=O)[C@H]2N(CCCC2)C(=O)[C@@H](CC)C=2C=C(OC)C(OC)=C(OC)C=2)C=CC=1)CC1=CC=C(OC)C(OC)=C1 GQLCLPLEEOUJQC-ZTQDTCGGSA-N 0.000 claims 2
- RJURFGZVJUQBHK-IIXSONLDSA-N actinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-IIXSONLDSA-N 0.000 claims 2
- 229940009456 adriamycin Drugs 0.000 claims 2
- 230000006907 apoptotic process Effects 0.000 claims 2
- 208000035269 cancer or benign tumor Diseases 0.000 claims 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims 2
- 210000003169 central nervous system Anatomy 0.000 claims 2
- 229960000640 dactinomycin Drugs 0.000 claims 2
- 230000002950 deficient Effects 0.000 claims 2
- 230000018044 dehydration Effects 0.000 claims 2
- 238000006297 dehydration reaction Methods 0.000 claims 2
- 238000006471 dimerization reaction Methods 0.000 claims 2
- 230000000408 embryogenic effect Effects 0.000 claims 2
- 210000002919 epithelial cell Anatomy 0.000 claims 2
- 201000003444 follicular lymphoma Diseases 0.000 claims 2
- 125000002446 fucosyl group Chemical group C1([C@@H](O)[C@H](O)[C@H](O)[C@@H](O1)C)* 0.000 claims 2
- 239000002622 gonadotropin Substances 0.000 claims 2
- 230000003394 haemopoietic effect Effects 0.000 claims 2
- 208000014829 head and neck neoplasm Diseases 0.000 claims 2
- 208000026278 immune system disease Diseases 0.000 claims 2
- 230000036039 immunity Effects 0.000 claims 2
- 230000001939 inductive effect Effects 0.000 claims 2
- 239000003446 ligand Substances 0.000 claims 2
- 229960001592 paclitaxel Drugs 0.000 claims 2
- 230000001323 posttranslational effect Effects 0.000 claims 2
- 230000035755 proliferation Effects 0.000 claims 2
- 206010038038 rectal cancer Diseases 0.000 claims 2
- 201000001275 rectum cancer Diseases 0.000 claims 2
- 229950004008 rimiducid Drugs 0.000 claims 2
- 230000011664 signaling Effects 0.000 claims 2
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims 2
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims 2
- 210000003171 tumor-infiltrating lymphocyte Anatomy 0.000 claims 2
- 241000701161 unidentified adenovirus Species 0.000 claims 2
- 241001529453 unidentified herpesvirus Species 0.000 claims 2
- 241000712461 unidentified influenza virus Species 0.000 claims 2
- 206010046766 uterine cancer Diseases 0.000 claims 2
- 125000001417 5'-guanylyl group Chemical group C=12N=C(N([H])[H])N([H])C(=O)C=1N=C([H])N2[C@@]1([H])[C@@](O[H])([H])[C@@](O[H])([H])[C@](C(OP(=O)(O[H])[*])([H])[H])([H])O1 0.000 claims 1
- 239000013607 AAV vector Substances 0.000 claims 1
- 208000024827 Alzheimer disease Diseases 0.000 claims 1
- 206010061424 Anal cancer Diseases 0.000 claims 1
- 208000007860 Anus Neoplasms Diseases 0.000 claims 1
- 101100350628 Arabidopsis thaliana PLL3 gene Proteins 0.000 claims 1
- 241000228212 Aspergillus Species 0.000 claims 1
- 208000036170 B-Cell Marginal Zone Lymphoma Diseases 0.000 claims 1
- 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 claims 1
- 102100021663 Baculoviral IAP repeat-containing protein 5 Human genes 0.000 claims 1
- 102100027314 Beta-2-microglobulin Human genes 0.000 claims 1
- 206010005003 Bladder cancer Diseases 0.000 claims 1
- 206010005949 Bone cancer Diseases 0.000 claims 1
- 208000018084 Bone neoplasm Diseases 0.000 claims 1
- 206010006143 Brain stem glioma Diseases 0.000 claims 1
- 235000002566 Capsicum Nutrition 0.000 claims 1
- 240000008574 Capsicum frutescens Species 0.000 claims 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims 1
- 201000009030 Carcinoma Diseases 0.000 claims 1
- 206010007953 Central nervous system lymphoma Diseases 0.000 claims 1
- 206010008342 Cervix carcinoma Diseases 0.000 claims 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims 1
- 102000002029 Claudin Human genes 0.000 claims 1
- 108050009302 Claudin Proteins 0.000 claims 1
- 206010009944 Colon cancer Diseases 0.000 claims 1
- 208000035473 Communicable disease Diseases 0.000 claims 1
- 201000003075 Crimean-Congo hemorrhagic fever Diseases 0.000 claims 1
- 108020004414 DNA Proteins 0.000 claims 1
- 241000725619 Dengue virus Species 0.000 claims 1
- 241000702421 Dependoparvovirus Species 0.000 claims 1
- 241001115402 Ebolavirus Species 0.000 claims 1
- 208000001976 Endocrine Gland Neoplasms Diseases 0.000 claims 1
- 206010014733 Endometrial cancer Diseases 0.000 claims 1
- 206010014759 Endometrial neoplasm Diseases 0.000 claims 1
- 101710121417 Envelope glycoprotein Proteins 0.000 claims 1
- 101710181478 Envelope glycoprotein GP350 Proteins 0.000 claims 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 claims 1
- 206010061850 Extranodal marginal zone B-cell lymphoma (MALT type) Diseases 0.000 claims 1
- 108010060374 FSH Receptors Proteins 0.000 claims 1
- 102100027627 Follicle-stimulating hormone receptor Human genes 0.000 claims 1
- 102000006395 Globulins Human genes 0.000 claims 1
- 108010044091 Globulins Proteins 0.000 claims 1
- 102000010956 Glypican Human genes 0.000 claims 1
- 108050001154 Glypican Proteins 0.000 claims 1
- 108050007237 Glypican-3 Proteins 0.000 claims 1
- 208000001204 Hashimoto Disease Diseases 0.000 claims 1
- 208000030836 Hashimoto thyroiditis Diseases 0.000 claims 1
- 241000711549 Hepacivirus C Species 0.000 claims 1
- 241000700721 Hepatitis B virus Species 0.000 claims 1
- 208000021519 Hodgkin lymphoma Diseases 0.000 claims 1
- 241000701027 Human herpesvirus 6 Species 0.000 claims 1
- 241000713340 Human immunodeficiency virus 2 Species 0.000 claims 1
- 241000829111 Human polyomavirus 1 Species 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 1
- 102100021892 Inhibitor of nuclear factor kappa-B kinase subunit alpha Human genes 0.000 claims 1
- 101710110357 Inhibitor of nuclear factor kappa-B kinase subunit alpha Proteins 0.000 claims 1
- 102100034349 Integrase Human genes 0.000 claims 1
- 102000003815 Interleukin-11 Human genes 0.000 claims 1
- 108090000177 Interleukin-11 Proteins 0.000 claims 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 claims 1
- 241000710843 Japanese encephalitis virus group Species 0.000 claims 1
- 208000008839 Kidney Neoplasms Diseases 0.000 claims 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 1
- 208000031671 Large B-Cell Diffuse Lymphoma Diseases 0.000 claims 1
- 206010023927 Lassa fever Diseases 0.000 claims 1
- 241000713666 Lentivirus Species 0.000 claims 1
- 208000028018 Lymphocytic leukaemia Diseases 0.000 claims 1
- 201000003791 MALT lymphoma Diseases 0.000 claims 1
- 208000025205 Mantle-Cell Lymphoma Diseases 0.000 claims 1
- 241001115401 Marburgvirus Species 0.000 claims 1
- 241000712079 Measles morbillivirus Species 0.000 claims 1
- 208000002030 Merkel cell carcinoma Diseases 0.000 claims 1
- 241000579048 Merkel cell polyomavirus Species 0.000 claims 1
- 208000025370 Middle East respiratory syndrome Diseases 0.000 claims 1
- 241000127282 Middle East respiratory syndrome-related coronavirus Species 0.000 claims 1
- 208000003250 Mixed connective tissue disease Diseases 0.000 claims 1
- 208000034578 Multiple myelomas Diseases 0.000 claims 1
- 241000711386 Mumps virus Species 0.000 claims 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 claims 1
- 241000187654 Nocardia Species 0.000 claims 1
- 244000004005 Nypa fruticans Species 0.000 claims 1
- 235000005305 Nypa fruticans Nutrition 0.000 claims 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 claims 1
- 102000012547 Olfactory receptors Human genes 0.000 claims 1
- 108050002069 Olfactory receptors Proteins 0.000 claims 1
- 108091034117 Oligonucleotide Proteins 0.000 claims 1
- 108700026244 Open Reading Frames Proteins 0.000 claims 1
- 101100497331 Oryza sativa subsp. japonica CRL5 gene Proteins 0.000 claims 1
- 206010033128 Ovarian cancer Diseases 0.000 claims 1
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 1
- 240000007019 Oxalis corniculata Species 0.000 claims 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
- 208000002606 Paramyxoviridae Infections Diseases 0.000 claims 1
- 208000000821 Parathyroid Neoplasms Diseases 0.000 claims 1
- 201000011152 Pemphigus Diseases 0.000 claims 1
- 208000002471 Penile Neoplasms Diseases 0.000 claims 1
- 206010034299 Penile cancer Diseases 0.000 claims 1
- 102100027913 Peptidyl-prolyl cis-trans isomerase FKBP1A Human genes 0.000 claims 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 claims 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 claims 1
- 208000007913 Pituitary Neoplasms Diseases 0.000 claims 1
- 201000005746 Pituitary adenoma Diseases 0.000 claims 1
- 206010061538 Pituitary tumour benign Diseases 0.000 claims 1
- 206010035226 Plasma cell myeloma Diseases 0.000 claims 1
- 108010051742 Platelet-Derived Growth Factor beta Receptor Proteins 0.000 claims 1
- 208000006994 Precancerous Conditions Diseases 0.000 claims 1
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 claims 1
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 claims 1
- 102100033810 RAC-alpha serine/threonine-protein kinase Human genes 0.000 claims 1
- 206010038389 Renal cancer Diseases 0.000 claims 1
- 208000006265 Renal cell carcinoma Diseases 0.000 claims 1
- 241000724205 Rice stripe tenuivirus Species 0.000 claims 1
- 241000713124 Rift Valley fever virus Species 0.000 claims 1
- 241000315672 SARS coronavirus Species 0.000 claims 1
- 206010039710 Scleroderma Diseases 0.000 claims 1
- 208000000453 Skin Neoplasms Diseases 0.000 claims 1
- 208000021712 Soft tissue sarcoma Diseases 0.000 claims 1
- 201000002661 Spondylitis Diseases 0.000 claims 1
- 208000005718 Stomach Neoplasms Diseases 0.000 claims 1
- 108010091105 Subfamily B ATP Binding Cassette Transporter Proteins 0.000 claims 1
- 102000018075 Subfamily B ATP Binding Cassette Transporter Human genes 0.000 claims 1
- 108010002687 Survivin Proteins 0.000 claims 1
- 230000006052 T cell proliferation Effects 0.000 claims 1
- 206010042971 T-cell lymphoma Diseases 0.000 claims 1
- 208000027585 T-cell non-Hodgkin lymphoma Diseases 0.000 claims 1
- 108010006877 Tacrolimus Binding Protein 1A Proteins 0.000 claims 1
- 208000024313 Testicular Neoplasms Diseases 0.000 claims 1
- 206010057644 Testis cancer Diseases 0.000 claims 1
- 208000007536 Thrombosis Diseases 0.000 claims 1
- 208000024770 Thyroid neoplasm Diseases 0.000 claims 1
- 201000005485 Toxoplasmosis Diseases 0.000 claims 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims 1
- 208000033559 Waldenström macroglobulinemia Diseases 0.000 claims 1
- 241000710886 West Nile virus Species 0.000 claims 1
- GJDFFYWUIWJIMO-UHFFFAOYSA-N [9-(2-butoxycarbonylphenyl)-6-(ethylamino)xanthen-3-ylidene]-ethylazanium;chloride Chemical compound Cl.CCCCOC(=O)C1=CC=CC=C1C1=C2C=CC(=NCC)C=C2OC2=CC(NCC)=CC=C21 GJDFFYWUIWJIMO-UHFFFAOYSA-N 0.000 claims 1
- 239000000853 adhesive Substances 0.000 claims 1
- 230000001070 adhesive effect Effects 0.000 claims 1
- 201000005188 adrenal gland cancer Diseases 0.000 claims 1
- 208000024447 adrenal gland neoplasm Diseases 0.000 claims 1
- 208000026935 allergic disease Diseases 0.000 claims 1
- 230000030741 antigen processing and presentation Effects 0.000 claims 1
- 210000000612 antigen-presenting cell Anatomy 0.000 claims 1
- 201000011165 anus cancer Diseases 0.000 claims 1
- 108010081355 beta 2-Microglobulin Proteins 0.000 claims 1
- 230000033228 biological regulation Effects 0.000 claims 1
- 230000001707 blastogenic effect Effects 0.000 claims 1
- 210000004271 bone marrow stromal cell Anatomy 0.000 claims 1
- YFSICBRXHDFNIR-UHFFFAOYSA-N butyl 2-(3-amino-4,5-dibromo-6-iminoxanthen-9-yl)benzoate;hydrochloride Chemical compound Cl.CCCCOC(=O)C1=CC=CC=C1C1=C2C=CC(=N)C(Br)=C2OC2=C(Br)C(N)=CC=C21 YFSICBRXHDFNIR-UHFFFAOYSA-N 0.000 claims 1
- 210000004899 c-terminal region Anatomy 0.000 claims 1
- 239000001390 capsicum minimum Substances 0.000 claims 1
- 239000001569 carbon dioxide Substances 0.000 claims 1
- 229910002092 carbon dioxide Inorganic materials 0.000 claims 1
- 201000010881 cervical cancer Diseases 0.000 claims 1
- 229910052804 chromium Inorganic materials 0.000 claims 1
- 239000011651 chromium Substances 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 208000029742 colonic neoplasm Diseases 0.000 claims 1
- 230000008878 coupling Effects 0.000 claims 1
- 238000010168 coupling process Methods 0.000 claims 1
- 238000005859 coupling reaction Methods 0.000 claims 1
- 208000035250 cutaneous malignant susceptibility to 1 melanoma Diseases 0.000 claims 1
- 208000017763 cutaneous neuroendocrine carcinoma Diseases 0.000 claims 1
- 230000016396 cytokine production Effects 0.000 claims 1
- 230000001086 cytosolic effect Effects 0.000 claims 1
- 231100000433 cytotoxic Toxicity 0.000 claims 1
- 230000001472 cytotoxic effect Effects 0.000 claims 1
- 210000004443 dendritic cell Anatomy 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 206010012818 diffuse large B-cell lymphoma Diseases 0.000 claims 1
- 239000000975 dye Substances 0.000 claims 1
- 201000004101 esophageal cancer Diseases 0.000 claims 1
- GETYPKQGOHYZCU-UHFFFAOYSA-N ethyl 2-(3-amino-4,5-dibromo-6-iminoxanthen-9-yl)benzoate;hydrochloride Chemical compound Cl.CCOC(=O)C1=CC=CC=C1C1=C2C=CC(=N)C(Br)=C2OC2=C(Br)C(N)=CC=C21 GETYPKQGOHYZCU-UHFFFAOYSA-N 0.000 claims 1
- 210000000416 exudates and transudate Anatomy 0.000 claims 1
- 210000002950 fibroblast Anatomy 0.000 claims 1
- 239000007850 fluorescent dye Substances 0.000 claims 1
- 206010017758 gastric cancer Diseases 0.000 claims 1
- 210000004392 genitalia Anatomy 0.000 claims 1
- 201000009277 hairy cell leukemia Diseases 0.000 claims 1
- 230000002489 hematologic effect Effects 0.000 claims 1
- 208000006454 hepatitis Diseases 0.000 claims 1
- 231100000283 hepatitis Toxicity 0.000 claims 1
- 230000001976 improved effect Effects 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 210000004263 induced pluripotent stem cell Anatomy 0.000 claims 1
- 230000002452 interceptive effect Effects 0.000 claims 1
- 201000002313 intestinal cancer Diseases 0.000 claims 1
- 230000004068 intracellular signaling Effects 0.000 claims 1
- 201000010982 kidney cancer Diseases 0.000 claims 1
- 230000003902 lesion Effects 0.000 claims 1
- 210000000265 leukocyte Anatomy 0.000 claims 1
- 201000007270 liver cancer Diseases 0.000 claims 1
- 208000014018 liver neoplasm Diseases 0.000 claims 1
- 210000002751 lymph Anatomy 0.000 claims 1
- 208000003747 lymphoid leukemia Diseases 0.000 claims 1
- 230000003211 malignant effect Effects 0.000 claims 1
- 208000029559 malignant endocrine neoplasm Diseases 0.000 claims 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 1
- 208000020984 malignant renal pelvis neoplasm Diseases 0.000 claims 1
- 208000026037 malignant tumor of neck Diseases 0.000 claims 1
- 208000026045 malignant tumor of parathyroid gland Diseases 0.000 claims 1
- 210000005075 mammary gland Anatomy 0.000 claims 1
- 201000007924 marginal zone B-cell lymphoma Diseases 0.000 claims 1
- 208000021937 marginal zone lymphoma Diseases 0.000 claims 1
- 230000001394 metastastic effect Effects 0.000 claims 1
- 206010061289 metastatic neoplasm Diseases 0.000 claims 1
- KKZJGLLVHKMTCM-UHFFFAOYSA-N mitoxantrone Chemical compound O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO KKZJGLLVHKMTCM-UHFFFAOYSA-N 0.000 claims 1
- 229960001156 mitoxantrone Drugs 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 230000035772 mutation Effects 0.000 claims 1
- 208000025113 myeloid leukemia Diseases 0.000 claims 1
- 210000000822 natural killer cell Anatomy 0.000 claims 1
- 208000015122 neurodegenerative disease Diseases 0.000 claims 1
- 208000002154 non-small cell lung carcinoma Diseases 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 238000006384 oligomerization reaction Methods 0.000 claims 1
- 210000003101 oviduct Anatomy 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 1
- 201000001976 pemphigus vulgaris Diseases 0.000 claims 1
- 231100000760 phototoxic Toxicity 0.000 claims 1
- 208000021310 pituitary gland adenoma Diseases 0.000 claims 1
- 210000005134 plasmacytoid dendritic cell Anatomy 0.000 claims 1
- 206010035485 plasmacytosis Diseases 0.000 claims 1
- 239000013612 plasmid Substances 0.000 claims 1
- 210000004180 plasmocyte Anatomy 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 208000016800 primary central nervous system lymphoma Diseases 0.000 claims 1
- 230000002062 proliferating effect Effects 0.000 claims 1
- 210000002307 prostate Anatomy 0.000 claims 1
- 208000015347 renal cell adenocarcinoma Diseases 0.000 claims 1
- 201000007444 renal pelvis carcinoma Diseases 0.000 claims 1
- 238000010839 reverse transcription Methods 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 201000000306 sarcoidosis Diseases 0.000 claims 1
- 210000003491 skin Anatomy 0.000 claims 1
- 201000000849 skin cancer Diseases 0.000 claims 1
- 241000894007 species Species 0.000 claims 1
- 206010041823 squamous cell carcinoma Diseases 0.000 claims 1
- 238000010186 staining Methods 0.000 claims 1
- 201000011549 stomach cancer Diseases 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- 201000003120 testicular cancer Diseases 0.000 claims 1
- 230000001732 thrombotic effect Effects 0.000 claims 1
- 201000002510 thyroid cancer Diseases 0.000 claims 1
- 210000001685 thyroid gland Anatomy 0.000 claims 1
- 230000001256 tonic effect Effects 0.000 claims 1
- 230000005747 tumor angiogenesis Effects 0.000 claims 1
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 claims 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims 1
- 241000701447 unidentified baculovirus Species 0.000 claims 1
- 241001430294 unidentified retrovirus Species 0.000 claims 1
- 201000005112 urinary bladder cancer Diseases 0.000 claims 1
- 206010046885 vaginal cancer Diseases 0.000 claims 1
- 208000013139 vaginal neoplasm Diseases 0.000 claims 1
- JXLYSJRDGCGARV-CFWMRBGOSA-N vinblastine Chemical compound C([C@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-CFWMRBGOSA-N 0.000 claims 1
- 229960003048 vinblastine Drugs 0.000 claims 1
- OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 claims 1
- 229960004528 vincristine Drugs 0.000 claims 1
- OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023120385A JP2023145589A (ja) | 2017-09-27 | 2023-07-25 | 共刺激のための新規のプラットフォーム、新規のｃａｒ設計、および養子細胞療法のための他の増強 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762564249P | 2017-09-27 | 2017-09-27 | |
| US62/564,249 | 2017-09-27 | ||
| PCT/US2018/053247 WO2019067805A1 (en) | 2017-09-27 | 2018-09-27 | NEW PLATFORMS FOR CO-STIMULATION, NEW CAR DESIGNS AND OTHER IMPROVEMENTS FOR ADOPTIVE CELL THERAPY |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023120385A Division JP2023145589A (ja) | 2017-09-27 | 2023-07-25 | 共刺激のための新規のプラットフォーム、新規のｃａｒ設計、および養子細胞療法のための他の増強 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021500861A JP2021500861A (ja) | 2021-01-14 |
| JP2021500861A5 true JP2021500861A5 (https=) | 2021-11-04 |
Family
ID=65902679
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020517377A Pending JP2021500861A (ja) | 2017-09-27 | 2018-09-27 | 共刺激のための新規のプラットフォーム、新規のｃａｒ設計、および養子細胞療法のための他の増強 |
| JP2023120385A Pending JP2023145589A (ja) | 2017-09-27 | 2023-07-25 | 共刺激のための新規のプラットフォーム、新規のｃａｒ設計、および養子細胞療法のための他の増強 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023120385A Pending JP2023145589A (ja) | 2017-09-27 | 2023-07-25 | 共刺激のための新規のプラットフォーム、新規のｃａｒ設計、および養子細胞療法のための他の増強 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US12570711B2 (https=) |
| EP (1) | EP3687553A4 (https=) |
| JP (2) | JP2021500861A (https=) |
| KR (1) | KR20200071079A (https=) |
| CN (1) | CN111629734A (https=) |
| AU (2) | AU2018338647B2 (https=) |
| BR (1) | BR112020005938A2 (https=) |
| CA (1) | CA3075806A1 (https=) |
| EA (1) | EA202090839A1 (https=) |
| IL (1) | IL273201B2 (https=) |
| MX (1) | MX2020004185A (https=) |
| SG (1) | SG11202002321YA (https=) |
| WO (1) | WO2019067805A1 (https=) |
| ZA (2) | ZA202002046B (https=) |
Families Citing this family (62)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3234120B1 (en) | 2014-12-15 | 2025-09-03 | The Regents of the University of California | Cytotoxic molecules responsive to intracellular ligands for selective t cell mediated killing |
| FI3240805T3 (fi) | 2014-12-15 | 2025-02-17 | Univ California | Cd19- ja cd20-vasteellinen bispesifinen tai-veräjän kimeerinen antigeenireseptori |
| PL3298033T5 (pl) | 2015-05-18 | 2023-10-30 | TCR2 Therapeutics Inc. | Kompozycje i zastosowania medyczne do reprogramowania TCR z zastosowaniem białek fuzyjnych |
| PL3368571T3 (pl) | 2015-10-30 | 2023-05-02 | The Regents Of The University Of California | Polipeptydy odpowiadające na transformujący czynnik wzrostu beta i sposoby ich zastosowania |
| EP3641806A4 (en) | 2017-06-22 | 2021-06-23 | University of Maryland, Baltimore | BROAD NEUTRALIZING ANTIBODIES AGAINST HIV |
| CN111201030B (zh) | 2017-07-25 | 2024-11-01 | 真和制药有限公司 | 通过阻断tim-3和其配体的相互作用治疗癌症 |
| JP2020537515A (ja) * | 2017-10-03 | 2020-12-24 | ジュノー セラピューティクス インコーポレイテッド | Ｈｐｖ特異的結合分子 |
| US12247060B2 (en) | 2018-01-09 | 2025-03-11 | Marengo Therapeutics, Inc. | Calreticulin binding constructs and engineered T cells for the treatment of diseases |
| WO2019173801A1 (en) * | 2018-03-09 | 2019-09-12 | Atreca, Inc. | Nucleic acids encoding anti-hiv antibodies |
| JP7599205B2 (ja) | 2018-06-01 | 2024-12-13 | アンヘレス セラピューティクス インコーポレイテッド | 細胞療法のための多様な抗原結合ドメイン、新規プラットフォームおよびその他の強化 |
| CA3105448A1 (en) | 2018-07-03 | 2020-01-09 | Elstar Therapeutics, Inc. | Anti-tcr antibody molecules and uses thereof |
| CA3118830A1 (en) * | 2018-11-07 | 2020-05-14 | Crispr Therapeutics Ag | Anti-ptk7 immune cell cancer therapy |
| WO2020160156A2 (en) | 2019-01-30 | 2020-08-06 | Immutics, Inc. | Anti-gal3 antibodies and uses thereof |
| US12419913B2 (en) | 2019-02-08 | 2025-09-23 | Dna Twopointo, Inc. | Modification of CAR-T cells |
| GB2599228B (en) | 2019-02-21 | 2024-02-07 | Marengo Therapeutics Inc | Multifunctional molecules that bind to T cell related cancer cells and uses thereof |
| CN119039441A (zh) | 2019-02-21 | 2024-11-29 | 马伦戈治疗公司 | 与nkp30结合的抗体分子及其用途 |
| CN113795262A (zh) * | 2019-04-08 | 2021-12-14 | 东莞凡恩世生物医药有限公司 | 人源化抗dll3嵌合抗原受体及其用途 |
| CA3136742A1 (en) * | 2019-05-01 | 2020-11-05 | Juno Therapeutics, Inc. | Cells expressing a chimeric receptor from a modified cd247 locus, related polynucleotides and methods |
| JP7562103B2 (ja) * | 2019-05-31 | 2024-10-07 | 国立大学法人信州大学 | Ａｌｋを標的とするキメラ抗原受容体発現細胞 |
| EP4527466A3 (en) | 2019-07-17 | 2025-06-18 | Legend Biotech Ireland Limited | Anti-dll3 chimeric antigen receptors and uses thereof |
| US12606612B2 (en) | 2019-07-31 | 2026-04-21 | The Wistar Institute Of Anatomy And Biology | Multivalent DNA antibody constructs and use thereof |
| WO2021035170A1 (en) * | 2019-08-21 | 2021-02-25 | Precision Biosciences, Inc. | Compositions and methods for tcr reprogramming using fusion proteins |
| JP7748935B2 (ja) * | 2019-08-27 | 2025-10-03 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | ＩＬ１３Ｒα２陽性ヒト腫瘍およびイヌ腫瘍を処置するための合成ＣＡＲ |
| US20210060070A1 (en) * | 2019-09-04 | 2021-03-04 | Tmunity Therapeutics Inc. | Adoptive cell therapy and methods of dosing thereof |
| EP4025598A1 (en) * | 2019-09-06 | 2022-07-13 | Eli Lilly and Company | Proteins comprising t-cell receptor constant domains |
| CN110483621A (zh) * | 2019-09-19 | 2019-11-22 | 河南省农业科学院 | 天然免疫库筛选识别环丙沙星单链抗体的核心序列及应用 |
| WO2021062313A1 (en) * | 2019-09-26 | 2021-04-01 | Board Of Regents, The University Of Texas System | Immunogenic egfr peptide compositions and their use in the treatment of cancer |
| EP3808765A1 (en) * | 2019-10-14 | 2021-04-21 | ETH Zurich | Cell line for tcr discovery and engineering and methods of use thereof |
| CN110903401A (zh) * | 2019-11-20 | 2020-03-24 | 浙江大学 | 一种靶向cd19的二代嵌合抗原受体及其表达载体与应用 |
| WO2021121228A1 (en) * | 2019-12-16 | 2021-06-24 | Nanjing Legend Biotech Co., Ltd. | Single domain antibodies and chimeric antigen receptors targeting bcma and methods of use thereof |
| AU2020416273A1 (en) | 2020-01-03 | 2022-07-28 | Marengo Therapeutics, Inc. | Anti-TCR antibody molecules and uses thereof |
| CN115397440A (zh) * | 2020-02-04 | 2022-11-25 | 西雅图儿童医院（Dba西雅图儿童研究所） | 用半抗原标记细胞刺激嵌合抗原受体t细胞的方法和组合物 |
| JP7735291B2 (ja) | 2020-02-21 | 2025-09-08 | エーアールエス ファーマシューティカルズ、インコーポレイテッド | ネクチン－４抗体コンジュゲートおよびその使用 |
| US12595311B2 (en) | 2020-03-02 | 2026-04-07 | The Regents Of The University Of California | Chimeric antigen receptors and related methods and compositions for the treatment of cancer |
| CA3171906A1 (en) | 2020-03-16 | 2021-09-23 | University Of Southern California | Novel antigen binding domains and synthetic antigen receptors incorporating the same |
| EP4121518A4 (en) * | 2020-03-16 | 2024-06-19 | Marengo Therapeutics, Inc. | MODIFIED CELL COMPOSITIONS AND METHODS OF USE |
| GB202004371D0 (en) * | 2020-03-26 | 2020-05-13 | Glaxosmithkline Ip Dev Ltd | CAR constructs |
| WO2021226289A2 (en) * | 2020-05-05 | 2021-11-11 | TCR2 Therapeutics Inc. | Compositions and methods for tcr reprogramming using cd70 specific fusion proteins |
| EP4157338A4 (en) | 2020-05-26 | 2024-11-13 | TrueBinding, Inc. | METHOD FOR TREATING INFLAMMATORY DISEASES BY GALECTIN-3 BLOCKING |
| EP4240832A4 (en) * | 2020-11-04 | 2025-01-01 | Fate Therapeutics, Inc. | Engineered ipsc and immune effector cells for heterogenous tumor control |
| KR20230118887A (ko) | 2020-12-03 | 2023-08-14 | 센츄리 쎄라퓨틱스 인코포레이티드 | 유전자 조작 세포 및 이의 용도 |
| US11661459B2 (en) | 2020-12-03 | 2023-05-30 | Century Therapeutics, Inc. | Artificial cell death polypeptide for chimeric antigen receptor and uses thereof |
| WO2022122709A1 (en) * | 2020-12-07 | 2022-06-16 | Sotio Biotech A.S. | Antibody-drug conjugates based on humanized cldn18.2 antibodies |
| CN112500497B (zh) * | 2020-12-14 | 2021-06-08 | 南京凯地医疗技术有限公司 | Cltx-nkg2d双特异性嵌合抗原受体细胞及其制备方法和应用 |
| AR124414A1 (es) | 2020-12-18 | 2023-03-22 | Century Therapeutics Inc | Sistema de receptor de antígeno quimérico con especificidad de receptor adaptable |
| WO2023019144A1 (en) * | 2021-08-10 | 2023-02-16 | The Regents Of The University Of California | Hla-a2-specific regulatory t cells |
| CN115881221B (zh) * | 2021-09-29 | 2025-12-16 | 上海市免疫学研究所 | 一种冠状病毒转录组鉴定分析方法及分析系统 |
| WO2023056194A2 (en) * | 2021-09-29 | 2023-04-06 | Chimera Bioengineering, Inc. | Compositions and methods for anti-tnmuc1 gold car t-cells |
| CN116102658B (zh) * | 2021-11-09 | 2025-04-29 | 四川大学华西医院 | 基于gas6构建的嵌合抗原受体免疫细胞制备及其应用 |
| KR102739632B1 (ko) | 2022-02-09 | 2024-12-05 | 한림대학교 산학협력단 | 항-cd20 키메릭 항원 수용체를 유효성분으로 포함하는 암의 예방 또는 치료용 약학적 조성물 및 이의 제조 방법 |
| WO2023192992A2 (en) * | 2022-03-31 | 2023-10-05 | The Wistar Institute Of Anatomy And Biology | Bispecific natural killer engagers that target siglec-7 |
| CN116058334B (zh) * | 2022-11-21 | 2023-08-08 | 中国人民解放军军事科学院军事医学研究院 | 一种可视化gvhd动物模型的构建方法及其应用 |
| CN115558021B (zh) * | 2022-12-01 | 2023-03-17 | 山东大学 | 一种转录因子、重组细胞及其在制备肿瘤治疗药物的应用 |
| WO2024226829A2 (en) * | 2023-04-26 | 2024-10-31 | Yale University | Enpp3-binding molecules, compositions formed therefrom, and methods of use thereof for the treatment of cancer |
| CN116445402B (zh) * | 2023-05-09 | 2025-04-25 | 中国科学院生态环境研究中心 | 红系祖细胞的扩增培养基、扩增培养方法及应用 |
| WO2025038646A1 (en) * | 2023-08-14 | 2025-02-20 | Intellia Therapeutics, Inc. | Cd70 car-t compositions and methods for cell-based therapy |
| WO2025084880A1 (ko) * | 2023-10-20 | 2025-04-24 | 주식회사 이온셀 | Ct83 항원에 결합하는 car-t 세포 및 이의 용도 |
| WO2025149667A1 (en) | 2024-01-12 | 2025-07-17 | Pheon Therapeutics Ltd | Antibody drug conjugates and uses thereof |
| CN120965855A (zh) * | 2024-02-21 | 2025-11-18 | 北京永泰瑞科生物科技有限公司 | 一种t细胞抗原受体及其制备方法和其应用 |
| CN118130793B (zh) * | 2024-02-26 | 2025-07-29 | 赣南医科大学 | 视网膜母细胞瘤的生物标志物cdk12及其应用 |
| WO2025215183A1 (en) * | 2024-04-11 | 2025-10-16 | Universität Heidelberg | Anti-cll1 binding agents |
| WO2025255267A1 (en) * | 2024-06-05 | 2025-12-11 | Dynamic Cell Therapies, Inc. | Engineered receptors for activation of regulatory t-cells |
Family Cites Families (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1247080A (en) | 1983-03-08 | 1988-12-20 | Commonwealth Serum Laboratories Commission | Antigenically active amino acid sequences |
| US6905680B2 (en) | 1988-11-23 | 2005-06-14 | Genetics Institute, Inc. | Methods of treating HIV infected subjects |
| US6352694B1 (en) | 1994-06-03 | 2002-03-05 | Genetics Institute, Inc. | Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells |
| US5858358A (en) | 1992-04-07 | 1999-01-12 | The United States Of America As Represented By The Secretary Of The Navy | Methods for selectively stimulating proliferation of T cells |
| US6534055B1 (en) | 1988-11-23 | 2003-03-18 | Genetics Institute, Inc. | Methods for selectively stimulating proliferation of T cells |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US5585362A (en) | 1989-08-22 | 1996-12-17 | The Regents Of The University Of Michigan | Adenovirus vectors for gene therapy |
| US5199942A (en) | 1991-06-07 | 1993-04-06 | Immunex Corporation | Method for improving autologous transplantation |
| US8211422B2 (en) | 1992-03-18 | 2012-07-03 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Chimeric receptor genes and cells transformed therewith |
| IL104570A0 (en) | 1992-03-18 | 1993-05-13 | Yeda Res & Dev | Chimeric genes and cells transformed therewith |
| US5350674A (en) | 1992-09-04 | 1994-09-27 | Becton, Dickinson And Company | Intrinsic factor - horse peroxidase conjugates and a method for increasing the stability thereof |
| US7175843B2 (en) | 1994-06-03 | 2007-02-13 | Genetics Institute, Llc | Methods for selectively stimulating proliferation of T cells |
| US6692964B1 (en) | 1995-05-04 | 2004-02-17 | The United States Of America As Represented By The Secretary Of The Navy | Methods for transfecting T cells |
| US7067318B2 (en) | 1995-06-07 | 2006-06-27 | The Regents Of The University Of Michigan | Methods for transfecting T cells |
| EP1958962A3 (en) | 1997-06-12 | 2013-05-01 | Novartis International Pharmaceutical Ltd. | Artificial antibody polypeptides |
| HK1047109A1 (zh) | 1999-10-15 | 2003-02-07 | University Of Massachusetts | 作为指定基因干预工具的rna干预轨迹基因 |
| US6326193B1 (en) | 1999-11-05 | 2001-12-04 | Cambria Biosciences, Llc | Insect control agent |
| US6797514B2 (en) | 2000-02-24 | 2004-09-28 | Xcyte Therapies, Inc. | Simultaneous stimulation and concentration of cells |
| KR20030032922A (ko) | 2000-02-24 | 2003-04-26 | 싸이트 테라피스 인코포레이티드 | 세포의 동시 자극 및 농축 |
| US6867041B2 (en) | 2000-02-24 | 2005-03-15 | Xcyte Therapies, Inc. | Simultaneous stimulation and concentration of cells |
| US7572631B2 (en) | 2000-02-24 | 2009-08-11 | Invitrogen Corporation | Activation and expansion of T cells |
| AU2001275474A1 (en) | 2000-06-12 | 2001-12-24 | Akkadix Corporation | Materials and methods for the control of nematodes |
| CA3058450A1 (en) * | 2006-10-19 | 2008-04-24 | Baylor College Of Medicine | Generating an immune response by inducing cd40 and pattern recognition receptors |
| CA2738031C (en) | 2008-09-22 | 2022-11-29 | Baylor College Of Medicine | Methods and compositions for generating an immune response by inducing cd40 and pattern recognition receptor adapters |
| WO2011059836A2 (en) | 2009-10-29 | 2011-05-19 | Trustees Of Dartmouth College | T cell receptor-deficient t cell compositions |
| US20120269814A1 (en) | 2009-11-10 | 2012-10-25 | Amgen Inc. | Anti-c mpl antibodies |
| US20110287038A1 (en) | 2010-04-16 | 2011-11-24 | Kevin Slawin | Method for treating solid tumors |
| CA2832540C (en) | 2011-04-08 | 2020-09-15 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Anti-epidermal growth factor receptor variant iii chimeric antigen receptors and use of same for the treatment of cancer |
| PT2768942T (pt) | 2011-10-17 | 2020-01-21 | Massachusetts Inst Technology | Entrega intracelular |
| KR101764096B1 (ko) * | 2011-11-28 | 2017-08-02 | 메르크 파텐트 게엠베하 | 항-ｐｄ-ｌ1 항체 및 그의 용도 |
| EP3404111A1 (en) | 2013-03-13 | 2018-11-21 | Health Research, Inc. | Compositions and methods for use of recombinant t cell receptors for direct recognition of tumor antigen |
| US9937207B2 (en) | 2013-03-21 | 2018-04-10 | Sangamo Therapeutics, Inc. | Targeted disruption of T cell receptor genes using talens |
| IN2013MU03610A (https=) | 2013-12-18 | 2015-04-24 | Dharmesh Mahendrabhai Shah | |
| BR112016018100A2 (pt) | 2014-02-07 | 2018-02-20 | Univ Mcmaster | acoplador antigênico de células t trifuncional, métodos e usos do mesmo |
| US10934346B2 (en) * | 2014-02-14 | 2021-03-02 | Bellicum Pharmaceuticals, Inc. | Modified T cell comprising a polynucleotide encoding an inducible stimulating molecule comprising MyD88, CD40 and FKBP12 |
| US20170335281A1 (en) | 2014-03-15 | 2017-11-23 | Novartis Ag | Treatment of cancer using chimeric antigen receptor |
| BR112017013981A2 (pt) * | 2015-01-26 | 2018-01-02 | Cellectis | receptores antigênicos quiméricos com uma única cadeia específicos anti-cll1 (sccars) para imunoterapia de câncer |
| HK1247123A1 (zh) | 2015-03-20 | 2018-09-21 | 生活燃料有限公司 | 治疗copd和其它炎症性病况的组合物和方法 |
| PL3298033T5 (pl) | 2015-05-18 | 2023-10-30 | TCR2 Therapeutics Inc. | Kompozycje i zastosowania medyczne do reprogramowania TCR z zastosowaniem białek fuzyjnych |
| HK1255161A1 (zh) * | 2015-07-15 | 2019-08-09 | Juno Therapeutics, Inc. | 用於过继性细胞治疗的工程细胞 |
| MX2018004721A (es) * | 2015-10-23 | 2018-07-06 | Eureka Therapeutics Inc | Construcciones quimericas anticuerpo/receptor de celulas t y usos de las mismas. |
| WO2017076308A1 (zh) * | 2015-11-04 | 2017-05-11 | 广州市香雪制药股份有限公司 | 识别ny-eso-1抗原短肽的tcr |
| CN105647871A (zh) * | 2016-01-27 | 2016-06-08 | 苏州佰通生物科技有限公司 | 一种可异体移植的嵌合抗原受体t细胞及制备方法 |
| KR20230148844A (ko) | 2016-03-29 | 2023-10-25 | 유니버시티 오브 써던 캘리포니아 | 암을 표적하는 키메라 항원 수용체 |
| US11768203B2 (en) | 2016-03-31 | 2023-09-26 | University Of Southern California | Highly sensitive and specific luciferase based reporter assay for antigen detection |
| EP4628587A3 (en) * | 2016-04-15 | 2026-02-25 | Memorial Sloan Kettering Cancer Center | Transgenic t cell and chimeric antigen receptor t cell compositions and related methods |
| WO2017192536A1 (en) * | 2016-05-02 | 2017-11-09 | University Of Kansas | Eliminating mhc restriction from the t cell receptor as a strategy for immunotherapy |
| US11377875B2 (en) | 2016-09-19 | 2022-07-05 | Level Home, Inc. | Deadbolt position sensing |
| EP3548055A4 (en) | 2016-12-02 | 2020-08-19 | University of Southern California | SYNTHETIC IMMUNE RECEPTORS AND THEIR PROCESSES FOR USE |
| JP7599205B2 (ja) * | 2018-06-01 | 2024-12-13 | アンヘレス セラピューティクス インコーポレイテッド | 細胞療法のための多様な抗原結合ドメイン、新規プラットフォームおよびその他の強化 |
| CN113286811B (zh) * | 2018-07-30 | 2024-12-06 | 南加利福尼亚大学 | 改善过继性细胞疗法的效力和安全性 |
-
2018
- 2018-09-27 WO PCT/US2018/053247 patent/WO2019067805A1/en not_active Ceased
- 2018-09-27 IL IL273201A patent/IL273201B2/en unknown
- 2018-09-27 KR KR1020207012047A patent/KR20200071079A/ko not_active Ceased
- 2018-09-27 EP EP18863755.7A patent/EP3687553A4/en active Pending
- 2018-09-27 CN CN201880073056.6A patent/CN111629734A/zh active Pending
- 2018-09-27 BR BR112020005938-2A patent/BR112020005938A2/pt unknown
- 2018-09-27 US US16/651,907 patent/US12570711B2/en active Active
- 2018-09-27 JP JP2020517377A patent/JP2021500861A/ja active Pending
- 2018-09-27 CA CA3075806A patent/CA3075806A1/en active Pending
- 2018-09-27 MX MX2020004185A patent/MX2020004185A/es unknown
- 2018-09-27 AU AU2018338647A patent/AU2018338647B2/en active Active
- 2018-09-27 SG SG11202002321YA patent/SG11202002321YA/en unknown
- 2018-09-27 EA EA202090839A patent/EA202090839A1/ru unknown
-
2020
- 2020-05-04 ZA ZA2020/02046A patent/ZA202002046B/en unknown
-
2022
- 2022-05-24 ZA ZA2022/05717A patent/ZA202205717B/en unknown
-
2023
- 2023-07-25 JP JP2023120385A patent/JP2023145589A/ja active Pending
-
2025
- 2025-08-28 AU AU2025223797A patent/AU2025223797A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021500861A5 (https=) | ||
| JP2023518049A5 (https=) | ||
| IL273201B1 (en) | Novel platforms for co-stimulation, novel car designs and other enhancements for adoptive cellular therapy | |
| JP2021525509A5 (https=) | ||
| JP2020500530A5 (https=) | ||
| JP7487112B2 (ja) | Ｃｄ１９指向性キメラ抗原受容体および免疫療法におけるその使用 | |
| JP2024518011A5 (https=) | ||
| US20240390496A1 (en) | Single-chain and multi-chain synthetic antigen receptors for diverse immune cells | |
| AU2021307614B2 (en) | Engineered immune cell for allotransplantation | |
| JP2025037871A5 (https=) | ||
| US20230028399A1 (en) | Bcma-directed cellular immunotherapy compositions and methods | |
| AU2025203096A1 (en) | Engineered immune cell expressing NK inhibitory molecule and use thereof | |
| JP2020517263A5 (https=) | ||
| CN114015656A (zh) | 用于同种异体移植的工程化免疫细胞 | |
| RU2018122106A (ru) | Буферы для стабилизации лентивирусных препаратов | |
| US20250319185A1 (en) | Bcma-directed cellular immunotherapy compositions and methods | |
| WO2021030153A2 (en) | Engineered t cell receptors and uses thereof | |
| JP2024519335A5 (https=) | ||
| JP2023518293A (ja) | 新規の組換え細胞表面マーカー | |
| JP2025520124A (ja) | キメラアダプターポリペプチドを含む組成物及び方法 | |
| CN117202921A (zh) | 用于多种免疫细胞的单链和多链合成抗原受体 | |
| JP2022516710A5 (https=) | ||
| WO2022267983A1 (zh) | 工程化免疫细胞及其用途 | |
| RU2842294C1 (ru) | Химерные цитокиновые рецепторы, содержащие домены, связывающие tgf-бета | |
| Rode et al. | T cell activation by monoclonal antibodies bound to tumor cells by a cell surface displayed single-chain antibody |